Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting lipid metabolism in metastatic prostate cancer
Tahlia Scheinberg, Blossom Mak, Lisa M. Butler, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 22

Showing 22 citing articles:

New insights into the therapeutic potentials of statins in cancer
Chengyu Liu, Hong Chen, Bicheng Hu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Acetyl-CoA metabolism as a therapeutic target for cancer
Guo Chen, Banghe Bao, Cheng Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115741-115741
Open Access | Times Cited: 18
Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 615-637
Closed Access | Times Cited: 5
Metabolic Reprogramming in Prostate Cancer: The Roles of HOXB13 and FASN in Tumor Progression and Therapy
Faisal Saeed, Lara R. Harik
(2025) Vol. 2, Iss. 1
Open Access
Unsupervised self-organising map classification of Raman spectra from prostate cell lines uncovers substratified prostate cancer disease states
Daniel J. West, Susan Stepney, Y. Hancock
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
Jesús M. Pérez‐Gómez, Antonio J. Montero‐Hidalgo, Antonio C. Fuentes-Fayos, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1165-1187
Open Access | Times Cited: 9
New insights into lipid metabolism and prostate cancer (Review)
Zhengliang Zhang, Weixi Wang, Piaoping Kong, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 8
APOA1 mRNA and serum APOA1 protein as diagnostic and prognostic biomarkers in gastric cancer
Fangfei Li, Mei Han, Xiaoyun Gao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2141-2154
Open Access | Times Cited: 2
Periprostatic Adipose Tissue: A New Perspective for Diagnosing and Treating Prostate Cancer
Hongliang Cao, Yishu Wang, Difei Zhang, et al.
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 204-217
Open Access | Times Cited: 5
Antidiabetic potential of Carica papaya L. and its constituents: From folkloric uses to products development
Akingbolabo Daniel Ogunlakin, Taiwo Rukayat Onifade, Oluwafemi Adeleke Ojo, et al.
Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426 (2023) Vol. 6, Iss. 6, pp. 126-126
Open Access | Times Cited: 4
Docetaxel-Induced Cell Death Is Regulated by a Fatty Acid-Binding Protein 12-Slug-Survivin Pathway in Prostate Cancer Cells
Rong‐Zong Liu, Mansi Garg, Xiaohong Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9669-9669
Open Access | Times Cited: 1
Alpha-1-B glycoprotein (A1BG) inhibits sterol-binding and export by CRISP2
Ola El Atab, Barkha Gupta, Zhu Han, et al.
Journal of Biological Chemistry (2024), pp. 107910-107910
Open Access | Times Cited: 1
Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: A systematic review
Yamilé López‐Hernández, Cristina Andrés‐Lacueva, David S. Wishart, et al.
Translational Oncology (2024) Vol. 51, pp. 102196-102196
Closed Access | Times Cited: 1
Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells
Andrew Hillowe, Chris Gordon, Liqun Wang, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292483-e0292483
Open Access | Times Cited: 3
Physical activity, dysfunctional metabolism, and antitumor immunity
Amy L. Shaver, Nikita Nikita, Bach V. Tran, et al.
Elsevier eBooks (2024)
Closed Access
“Adiponcosis interplay: adipose tissue, microenvironment and prostate cancer”
Erika Di Zazzo, Biagio Barone, Felice Crocetto
Journal of Basic and Clinical Physiology and Pharmacology (2024) Vol. 35, Iss. 3, pp. 101-103
Closed Access
Fatty acid diet and prostate cancer: a treasure hunt or a wild goose chase?
Georges Mjaess, Thierry Roumeguère, Kéziah Korpak, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3
Wen Liu, Jun Deng, Xiaojun Tao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 4
Closed Access
Physical activity, dysfunctional metabolism, and antitumor immunity
Amy L. Shaver, Nikita Nikita, Bach V. Tran, et al.
Elsevier eBooks (2024)
Closed Access
Nodularin‐R Synergistically Enhances Abiraterone Against Castrate‐ Resistant Prostate Cancer via PPP1CA Inhibition
Yao Huang, Yi Cen, Hualing Wu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 22
Open Access
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy
Rhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer
Evelina La Civita, Gianluigi Carbone, Enrico Sicignano, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2023) Vol. 34, Iss. 3, pp. 245-247
Closed Access | Times Cited: 1
Page 1

Scroll to top